Dublin, June 26, 2019 (GLOBE NEWSWIRE) -- The "US Gout Market and Competitive Landscape - 2019" report has been added to ResearchAndMarkets.com's offering.

This latest research provides comprehensive insights into Gout pipeline products, Gout epidemiology, Gout market valuations and forecast, Gout drugs sales and competitive landscape in the US.

The research is classified into seven sections - Gout treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope

  • Gout pipeline: Find out the products in clinical trials for the treatment of Gout by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
  • Gout epidemiology: Find out the number of patients diagnosed (prevalence) with Gout in the US
  • Gout drugs: Identify key products marketed and prescribed for Gout in the US, including trade name, molecule name, and company
  • Gout drugs sales: Find out the sales revenues of Gout drugs in the US
  • Gout market valuations: Find out the market size for Gout drugs in 2018 in the US. Find out how the market advanced from 2014 and forecast to 2024
  • Gout drugs market share: Find out the market shares for key Gout drugs in the US

Benefits of this Research

  • Support monitoring and reporting national Gout market analysis and sales trends
  • Track competitor drugs sales and market share in the US Gout market
  • Track competitive developments in Gout market and present key issues and learnings
  • Synthesize insights for Gout market and products to drive business performance
  • Answer key business questions about the Gout market
  • Evaluate commercial market opportunity assessment, positioning, and segmentation for Gout products
  • Supports decision making in R&D to long term marketing strategies

Key Topics Covered
1) Gout Treatments
2) Gout Pipeline
3) US Gout Epidemiology
4) Marketed Drugs for Gout in US
5) US Gout Market Size and Forecast
6) US Gout Products Sales and Forecast
7) US Gout Market Competitive Landscape
8) Methodology

List of Tables
1. Gout Phase 3 Clinical Trials, 2019
2. Gout Phase 2 Clinical Trials, 2019
3. Gout Phase 1 Clinical Trials, 2019
4. Gout Epidemiology, US, 2014 - 2024
5. Marketed Drugs for Gout, US, 2018
6. Gout Market Size and Forecast ($), US, 2014 - 2024
7. Gout Product Sales ($), US, 2014 - 2024

List of Figures
1. Gout Epidemiology, US, 2014 - 2024
2. Gout Market Size and Forecast ($), US, 2014 - 2024
3. Gout Products Market Share (%), US, 2018

For more information about this report visit https://www.researchandmarkets.com/r/yd55kn

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Immune Disorders Drugs, Endocrine and Metabolic Disorders Drugs, Musculoskeletal Disorders Drugs